IP Library Granted Patent US 9,695,204
Granted Patent B2
US 9,695,204 · App. 15/178,967 · Granted Jul 4, 2017

Pharmaceutical process and intermediates

Inventors: Benedict McKeever (Macclesfield, GB); Louis Joseph Diorazio (Macclesfield, GB); Martin Francis Jones (Macclesfield, GB); Leigh Ferris (Macclesfield, GB); Sophie Laure Marie Janbon (Macclesfield, GB); Pawel Stanislaw Siedlecki (Macclesfield, GB); Gwydion Huw Churchill (Macclesfield, GB); Peter Alan Crafts (Aberdeenshire, GB)
Assignee: Rigel Pharmaceuticals, Inc.
C07F9/06C07F9/6561
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,695,204
App. No.
15/178,967
Granted
Jul 4, 2017
Kind
B2
Abstract

The present disclosure provides for processes and intermediates in the large-scale manufacture of the compound of formula (I) or hydrates thereof.

Claims (23)

1. A compound which is a triethylammonium salt of the compound of formula (II)

2. The compound according to claim 1 , wherein the stoichiometric ratio of triethylamine to the compound of formula (II) is between 0.5:1 and 2.5:1.

3. The compound according to claim 2 the stoichiometric ratio of triethylamine to the compound of formula (II) is between 1.5:1 and 2.5:1.

4. The compound according to claim 2 the stoichiometric ratio of triethylamine to the compound of formula (II) is about 2:1.

5. The compound according to claim 1 that is the bis(triethylammonium) salt of the compound of formula (II).

6. The compound according to claim 2 that is the bis(triethylammonium) salt of the compound of formula (II).

7. The compound according to claim 3 that is the bis(triethylammonium) salt of the compound of formula (II).

8. The compound according to claim 4 that is the bis(triethylammonium) salt of the compound of formula (II).

9. A method forming an amine salt of the compound of formula (II)

comprising,

(i) combining a solution of the amine in a polar solvent and water with an amide solvate of the compound of formula (II); and

(ii) filtering the reaction mixture.

10. The method of claim 9 wherein the polar solvent is selected from an alcohol, acetone, acetonitrile and dimethylsulfoxide.

11. The method of claim 10 , wherein the polar solvent is isopropanol.

12. The method of claim 9 , wherein the formation of the amine salt is carried out at a temperature not exceeding 70° C.

13. The method of claim 10 , wherein the formation of the amine salt is carried out at a temperature in the range of from about 0° C. to not exceeding 60° C.

14. The method of claim 10 , wherein the formation of the amine salt is carried out at a temperature in the range of from about 0° C. to not exceeding 50° C.

15. The method of claim 10 , wherein the formation of the amine salt is carried out at a temperature in the range of from about 0° C. to not exceeding 40° C.

16. The method of claim 10 , wherein the formation of the amine salt is carried out at a temperature in the range of from about 0° C. to not exceeding 30° C.

17. The method of claim 10 , wherein the formation of the amine salt is carried out at a temperature in the range of from about 0° C. to not exceeding 20° C.

18. The method of claim 10 , wherein the formation of the amine salt is carried out at a temperature in the range of from about 0° C. to not exceeding 10° C.

19. The method of claim 10 , wherein the formation of the amine salt is carried out at a temperature in the range of from about 10° C. to about 30° C.

20. The method of claim 10 , wherein the formation of the amine salt is carried out at ambient temperature.

Assignments (5)
SECURITY INTEREST Recorded May 8, 2026
From: RIGEL PHARMACEUTICALS, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 075576/0880 →
SECURITY INTEREST Recorded Aug 25, 2022
From: RIGEL PHARMACEUTICALS, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 061327/0712 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2017
From: ASTRAZENECA UK LIMITED
To: ASTRAZENECA AB
Reel/Frame 042311/0519 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2017
From: ASTRAZENECA AB
To: RIGEL PHARMACEUTICALS, INC.
Reel/Frame 042311/0542 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2017
From: MCKEEVER, BENEDICT; DIORAZIO, LOUIS JOSEPH; JONES, MARTIN FRANCIS; JANBON, SOPHIE LAURE MARIE; FERRIS, LEIGH; SIEDLECKI, PAWEL STANISLAW; CHURCHILL, GWYDION HUW; CRAFTS, PETER ALAN
To: ASTRAZENECA UK LIMITED
Reel/Frame 042434/0568 →
Continuity (3)
Division 14576544 · Dec 19, 2014
Provisional Application 61919671 · Dec 20, 2013
Related Publication 20160355531A1 · Dec 8, 2016